PepGen (PEPG) Other financing activities (2023 - 2026)
PepGen (PEPG) reported Other financing activities of $7000.0 for Q1 2026, up 100.01% sequentially from -$107.8 million in Q4 2025.
PepGen (PEPG) Other financing activities (2023 - 2026) Analysis & Trends
PepGen (PEPG) has 4 years of Other financing activities data on file, last reported at $7000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $7000.0; the trailing twelve-month figure through Mar 2026 stood at $299000.0 (changed N/A YoY), and the FY2025 full-year result was $292000.0, down 99.62% from the prior year.
- Other financing activities climbed to $7000.0 in Q1 2026, from -$107.8 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $108.1 million in Q3 2025 to a low of -$107.8 million in Q4 2025.
- A 4-year average of $11.1 million and a median of $85000.0 in 2023 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 59036.92% in 2024, while the deepest fall reached 59036.92% in 2024.
- Tracing PEPG's Other financing activities over 4 years: stood at $38000.0 in 2023, then surged by 202210.53% to $76.9 million in 2024, then sank by 240.23% to -$107.8 million in 2025, then soared by 100.01% to $7000.0 in 2026.
- Business Quant data shows PEPG's Other financing activities at $7000.0 in Q1 2026, -$107.8 million in Q4 2025, and $108.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | -107.81 Mn |
| Dec 31, 2025 | -107.81 Mn |
| Sep 30, 2025 | 108.10 Mn |
| Sep 30, 2025 | 108.10 Mn |
| Mar 31, 2024 | 76.88 Mn |
| Mar 31, 2024 | 76.88 Mn |
| Dec 31, 2023 | 38,000.00 |
| Dec 31, 2023 | 38,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | 130,000.00 |
| Mar 31, 2023 | 130,000.00 |